Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ducloux

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 23, 2014
Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized studyD Cantarovich, L Rostaing, N Kamar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 31, 2016
Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infectionsT Crepin, E Gaiffe, C Courivaud, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2015
ATG-induced accelerated immune senescence: clinical implications in renal transplant recipientsT Crepin, C Carron, C Roubiou, et al.
Journal of Transplantation|August 14, 2010
Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow UpL Frimat, E Cassuto-Viguier, F Provôt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2006
Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' studyL Frimat, E Cassuto-Viguier, B Charpentier, et al.
Trials|June 23, 2019
PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled studyE Gaiffe, T Crepin, J Bamoulid, et al.
Transplantation Proceedings|November 23, 2006
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipientsL Rostaing, G Mourad, N Kamar, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 23, 2014
Early corticosteroid avoidance in kidney transplant recipients receiving ATG-F induction: 5-year actual results of a prospective and randomized studyD Cantarovich, L Rostaing, N Kamar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 31, 2016
Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infectionsT Crepin, E Gaiffe, C Courivaud, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 12, 2015
ATG-induced accelerated immune senescence: clinical implications in renal transplant recipientsT Crepin, C Carron, C Roubiou, et al.
Journal of Transplantation|August 14, 2010
Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow UpL Frimat, E Cassuto-Viguier, F Provôt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 20, 2006
Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' studyL Frimat, E Cassuto-Viguier, B Charpentier, et al.
Trials|June 23, 2019
PRODIG (Prevention of new onset diabetes after transplantation by a short term treatment of Vildagliptin in the early renal post-transplant period) study: study protocol for a randomized controlled studyE Gaiffe, T Crepin, J Bamoulid, et al.
Transplantation Proceedings|November 23, 2006
Tolerability of enteric-coated mycophenolate sodium to 1 year in combination with cyclosporine and corticosteroids in renal transplant recipientsL Rostaing, G Mourad, N Kamar, et al.
Pageof 8